<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03200743</url>
  </required_header>
  <id_info>
    <org_study_id>20170513</org_study_id>
    <nct_id>NCT03200743</nct_id>
  </id_info>
  <brief_title>Catestatin and Hypertension in Pregnancy</brief_title>
  <official_title>Relationship Between Catestatin and Pregnant Hypertensive Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yuchen Pan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University Third Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Catestatin is a kind of protein involved with cardiovascular disease. Accumulated evidence
      shows that Catestatin may be a predictor of primary hypertension, but whether it plays the
      same role in pregnant hypertensive disorders needs to be determined. By measuring the plasma
      level of Catestatin, main biochemical marks and UCG in healthy pregnancy and pregnancy with
      hypertension, the research may contribute to this problem.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 14, 2017</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>18 Years</target_duration>
  <primary_outcome>
    <measure>plasma level of Catestatin</measure>
    <time_frame>once at the specified enrollment period</time_frame>
    <description>plasma level of Catestatin with the unit &quot;mmol/l&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood pressure</measure>
    <time_frame>the specified enrollment period,42 days and 2 months after the pregnancy</time_frame>
    <description>systolic and diastolic blood pressure with the unit &quot;mmHg&quot;</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Pre-Eclampsia</condition>
  <condition>Eclampsia</condition>
  <condition>Hypertension, Pregnancy-Induced</condition>
  <condition>Hypertension in Pregnancy</condition>
  <arm_group>
    <arm_group_label>Hpertension</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Health</arm_group_label>
  </arm_group>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients hospitalized in Peking University Third Hospital maternity ward after May, 2017
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy pregnancy women

          -  Pregnancy women with hypertension

               1. Despite the pregnant gestational age , systolic blood pressure ≥140 mm Hg OR a
                  diastolic blood pressure of ≥90 mm Hg measured three times more than 24 hours
                  apart

               2. Pregnant gestational age &gt; 20 weeks, systolic blood pressure ≥140 mm Hg OR a
                  diastolic blood pressure of ≥90 mm Hg measured twice more than 4 hours apart

        Exclusion Criteria:

          -  Lack of blood sample at the specified enrollment period

          -  Women who refuse the study

          -  Other illness which needs medications interfering with blood pressure (eg: Asthma
             requiring systemic steroids)

          -  Known coronary artery disease or heart failure

          -  Serious medical illness (eg: renal insufficiency, congestive heart disease, chronic
             respiratory insufficiency, uncontrolled infection).

          -  multiple endocrine neoplasia or Cushing's syndrome or mixed tumours or
             pheochromocytoma or medullary thyroid carcinoma.

          -  previous history of malignant tumour, with the exception of carcinoma in situ of the
             uterine cervix or non-melanoma skin cancer

          -  renal insufficiency
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yuchen Pan, MD</last_name>
    <phone>+8618810533382</phone>
    <email>panyuchen@bjmu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dan Zhu, MD</last_name>
    <email>andrea_zhu@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking University Third Hospital</name>
      <address>
        <city>Beijin</city>
        <state>Beijing</state>
        <zip>100191</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuchen Pan, MD</last_name>
      <phone>+8618810533382</phone>
      <email>panyuchen@bjmu.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Dan Zhu, MD</last_name>
      <email>andrea_zhu@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 19, 2017</study_first_submitted>
  <study_first_submitted_qc>June 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 27, 2017</study_first_posted>
  <last_update_submitted>June 26, 2017</last_update_submitted>
  <last_update_submitted_qc>June 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Peking University Third Hospital</investigator_affiliation>
    <investigator_full_name>Yuchen Pan</investigator_full_name>
    <investigator_title>Peking University Third Hospital</investigator_title>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <keyword>Pregnancy</keyword>
  <keyword>Catestatin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Eclampsia</mesh_term>
    <mesh_term>Pre-Eclampsia</mesh_term>
    <mesh_term>Hypertension, Pregnancy-Induced</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

